Identification of circulating risk biomarkers for cognitive decline in a large community-based population in

Yu Kang1,2, Zijuan Feng1, Qian Zhang3

  • 1Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.

Insights

This study identified common and distinct risk factors for mild cognitive impairment (MCI) and dementia in Chongqing. Blood biomarkers correlate with these factors, offering insights for targeted interventions in cognitive decline.

Area of Science:

  • Gerontology
  • Neuroscience
  • Epidemiology

Background:

  • Cognitive decline, including mild cognitive impairment (MCI) and dementia, poses a significant public health challenge, particularly in aging populations.
  • Understanding the interplay between established risk factors and underlying biological mechanisms is crucial for effective prevention and management.

Purpose of the Study:

  • To investigate the relationship between blood-based pathologies and known risk factors for cognitive decline in a large, community-based cohort in Chongqing.
  • To identify shared and distinct risk factors contributing to MCI and dementia.
  • To explore correlations between risk factors and specific circulating biomarkers.

Main Methods:

  • Recruitment of 26,554 residents aged 50 years and older from Chongqing.
  • Application of multinomial logistic regression models to assess cognition level risk factors.
  • Utilized propensity score matching and linear mixed effects models to analyze biomarker associations.

Main Results:

  • Identified shared risk factors for MCI and dementia (e.g., age, lower education, stroke history) and unique factors for each stage.
  • Age, education, occupation, hypertension, and epilepsy were linked to MCI progression to dementia.
  • Correlations found between risk factors and biomarkers like NfL, GFAP, and Aβ, indicating axonal damage, glial activation, and amyloid pathology.

Conclusions:

  • Common and distinct risk factors necessitate tailored interventions for different stages of cognitive decline.
  • Observed correlations with blood biomarkers highlight potential targets for therapeutic strategies and disease management.
  • Findings provide valuable insights into the biological underpinnings of cognitive impairment in an aging Chinese population.
Abstract